NRG Therapeutics
nrgtherapeutics.com
Actively hiring
Neurology & CNS Therapeutics
Biotechnology
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
201-500
employees, estimated range
Backers
2
M Ventures, Novartis Venture Fund
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
M Ventures 
Novartis Venture Fund Similar startupsby what they do, their industry and backers
Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience…
Brenig Therapeutics develops innovative small-molecule therapies for neurodegenerative diseases, including LRRK2 inhibitors targeting…
Boldly advancing the next generation of medicines for Alzheimer’s Disease and Related Dementias.
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
We’re building a pipeline of next-generation therapeutics focused on broadening the treatment paradigm for migraine and other headache…
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…
News
Queen Square MND Centre 7th Annual ALS/MND International Symposium
Queen Square MND Centre 7th Annual ALS/MND International Symposium 11 September 2026 London, UK View event website
Read more
Report
My Name'5 Doddie Foundation's Discovery Network Showcase 2026
My Name'5 Doddie Foundation's Discovery Network Showcase 2026 10 September 2026 London, UK View Foundation's website
Read more
Report
ALS Drug NRG5051 Targets Mitochondrial Pore to Protect Neurons
NRG Therapeutics CEO Spotlight Video SBC Watch now
Read more
Report
New ALS drug data reveal a mitochondrial fix
NRG Therapeutics CEO Spotlight Video SBC Watch now
Read more
Report
Coulter Partners places Claus Sundgreen, M.D. as Chief Medical Officer at NRG Therapeutics
NRG Therapeutics CEO Spotlight Video SBC Watch now
Read more
Report
Pro access
Upgrade to see all 12 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.